Transcriptional regulation of scar gene expression in primary astrocytes
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The failure of the adult injured spinal cord to support axonal regeneration is in part attributed to the glial scar. Reactive astrocytes constitute a major cellular component of the glial scar and are heterogeneous with respect to the extracellular matrix proteins that they secrete. Astrocytes may produce antiregenerative molecules such as chondroitin sulphate proteoglycans (CSPGs) or proregenerative molecules such as laminin and fibronectin. While many different CSPGs are expressed after spinal cord injury (SCI) they all rely on the same enzymes, xylosyltransferase‐I and ‐II (XT‐I, XT‐II) and chondroitin 4‐sulfotransferase (C4ST) to add the repulsive chondroitin sulfate side chains to their core proteins. We show that XT‐I, XT‐II, and C4ST are part of a CSPG biosynthetic gene (CBG) battery. Using primary astrocyte cultures and quantitative PCR we demonstrate that TGFβ2, PDGF, and IL‐6 induce the expression of CBGs, laminin and fibronectin by several‐fold. We further show that over‐expression of the transcription factor SOX9 also strongly induces the expression of CBGs but does not increase the expression of laminin or fibronectin. Correspondingly, SOX9 knock‐down in primary astrocytes causes a decrease in CBG and an increase in laminin and fibronectin mRNA levels. Finally, we show that the in vivo expression profiles of TGFβ2, PDGF, IL‐6, and SOX9 are consistent with their potential roles in differentially regulating CBGs, laminin and fibronectin gene expression in the injured spinal cord. This work suggests that SOX9 levels may be pivotal in determining the balance of pro‐ and anti‐regenerative extracellular matrix molecules produced by astrocytes. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chondroitinase ABC promotes functional recovery after spinal cord injury
Bradbury, E. J., Moon, L. D. F., Popat, R. J., King, V. R., Bennett, G. S., Patel, P. N., Fawcett, J. W., & McMahon, S. B. (2002) · Nature · doi:10.1038/416636a · Cited by 2,357 · cited 1×
“After 12 h or 3, 7, 21, or 42 days, the rats were anesthetized with 1:2 ratio of ketamine: xylazine (0.13 mL/100 g) the injured segment of the spinal cord was removed, immediately homogenized in ice cold Trizol solution (Invitrogen) and the RNA extracted as described (Carmel et al., 2001).”
MethodInfluentialThe Sox9 transcription factor determines glial fate choice in the developing spinal cord
Stolt, C. C., Lommes, P., Sock, E., Chaboissier, M.-C., Schedl, A., & Wegner, M. (2003) · Genes & Development · doi:10.1101/gad.259003 · Cited by 636 · cited 1×
“SOX9 does not have a previously described role in scar formation, but it plays an important role in astrocyte development (Kordes et al., 2005; Stolt et al., 2003) and positively regulates the expression of ECM genes during chondrogenesis (Furumatsu et al., 2005; Kawakami et al., 2005; Wehrli et…”
BackgroundDavies, S. J. A., Goucher, D. R., Doller, C., & Silver, J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05810.1999 · Cited by 606 · cited 1×
“Chondroitin sulfate proteoglycans (CSPGs) are probably the most important of the inhibitory molecules produced by reactive astrocytes (Eddleston and Mucke, 1993; Fawcett and Asher, 1999; Silver and Miller, 2004).”
BackgroundMcKeon, R. J., Jurynec, M. J., & Buck, C. R. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-24-10778.1999 · Cited by 480 · cited 11×
“Thus we suggest that the predominance of CSPGs at the spinal lesion site may depend in part on the expression levels of the transcription factor SOX9 which differentially regulates regeneration-inhibiting and promoting ECM proteins expressed in the injured spinal cord.”
BackgroundInfluential
Cited by
Molecular dissection of reactive astrogliosis and glial scar formation
Sofroniew, M. V. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.08.002 · Cited by 2,594
Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke
Liu, Z., & Chopp, M. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.008 · Cited by 590
Reactive Astrogliosis after Spinal Cord Injury—Beneficial and Detrimental Effects
Karimi-Abdolrezaee, S., & Billakanti, R. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8287-4 · Cited by 331
A1/A2 astrocytes in central nervous system injuries and diseases: Angels or devils?
Fan, Y.-Y., & Huo, J. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105080 · Cited by 304
Astrocytes: Targets for Neuroprotection in Stroke
Barreto, G., E. White, R., Ouyang, Y., Xu, L., & G. Giffard, R. (2011) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/187152411796011303 · Cited by 281
Chondroitin-4-sulfation negatively regulates axonal guidance and growth
Wang, H., Katagiri, Y., McCann, T. E., Unsworth, E., Goldsmith, P., Yu, Z.-X., Tan, F., Santiago, L., Mills, E. M., Wang, Y., et al. (2008) · Journal of Cell Science · doi:10.1242/jcs.032649 · Cited by 243
“Conversely, only a small percentage of 4-sulfation was reported to increase in vivo following injury, even though 4-sulfated disaccharides are the predominant species in the normal brain (Gris et al., 2007; Mitsunaga et al., 2006; Properzi et al., 2005).”
BackgroundAstrogliosis during acute and chronic cuprizone demyelination and implications for remyelination
Hibbits, N., Yoshino, J., Le, T. Q., & Armstrong, R. C. (2012) · ASN Neuro · doi:10.1042/an20120062 · Cited by 125
“Significant but relatively mild up-regulation is observed for Sox9, a transcription factor associated with astrocyte synthesis of genes involved with the production of chondroitin sulphate side chains (Gris et al., 2007).”
Background
Metadata
- Authors
- Gris, P., Tighe, A., Levin, D., Sharma, R., & Brown, A.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2007-06-27
- Volume
- 55
- Issue
- 11
- Pages
- 1145-1155
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2101952568
- Cited by
- 130
- References
- 4
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.